0.375
0.00 (0.00%)
| Penutupan Terdahulu | 0.375 |
| Buka | 0.370 |
| Jumlah Dagangan | 1,900,115 |
| Purata Dagangan (3B) | 1,999,485 |
| Modal Pasaran | 146,035,872 |
| Harga / Jualan (P/S) | 1.98 |
| Harga / Buku (P/B) | 7.28 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| EPS Cair (TTM) | -0.200 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.00% |
| Nisbah Semasa (MRQ) | 7.22 |
| Aliran Tunai Operasi (OCF TTM) | -65.94 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -48.04 M |
| Pulangan Atas Aset (ROA TTM) | -86.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -151.39% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (AU) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | PARA BIO FPO [PAR] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | -2.0 |
| Purata | 0.25 |
|
Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia. The firm is engaged in developing injectable pentosan polysulphate sodium (iPPS) for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. The company has registered the trademarks Zilosul and Rhinosul for the commercialization of iPPS. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 12.31% |
| % Dimiliki oleh Institusi | 15.40% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |